InvestSMART

Emyria Limited (ASX: EMD) - Announcements

- Current share price for EMD : $0.048

ASX company news and announcements for Emyria Limited (EMD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Emyria Limited (EMD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Emyria Limited (EMD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Emyria Limited (EMD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$39 Proposed issue of securities - EMD 23 Apr 2024 9:54AM $0.056 $0.048 fallen by 14.29%
$39 Emyria Receives Bids of $2.3M to Expand Clinical Services 23 Apr 2024 9:53AM $0.056 $0.048 fallen by 14.29%
$39 Trading Halt 19 Apr 2024 9:14AM $0.056 $0.048 fallen by 14.29%
$39 Emyria Opens Empax Centre to Advance Mental Health Care 10 Apr 2024 8:23AM $0.062 $0.048 fallen by 22.58%
$39 Emyria Expands Specialist AP Team - First Female for MDMA-AT 5 Apr 2024 8:25AM $0.061 $0.048 fallen by 21.31%
$39 Emyria, Reach Wellness Enter MDMA-AT Research Agreement 3 Apr 2024 8:25AM $0.059 $0.048 fallen by 18.64%
$39 Notification of cessation of securities - EMD 19 Mar 2024 6:19PM $0.060 $0.048 fallen by 20%
$39 Response to ASX Aware Query 12 Mar 2024 5:58PM $0.070 $0.048 fallen by 31.43%
$39 Response to ASX Price Query 8 Mar 2024 9:56AM $0.063 $0.048 fallen by 23.81%
$39 Emyria Half Year Results FY2024 29 Feb 2024 9:25AM $0.047 $0.048 risen by 2.13%
$39 Appendix 4D and Half Year End Financial Report 28 Feb 2024 5:28PM $0.047 $0.048 risen by 2.13%
$39 Notification of cessation of securities - EMD 23 Feb 2024 7:47PM $0.049 $0.048 fallen by 2.04%
$39 Webinar Presentation 2 Feb 2024 8:23AM $0.054 $0.048 fallen by 11.11%
$39 December 2023 Quarterly Activities Report and Appendix 4C 31 Jan 2024 9:32AM $0.051 $0.048 fallen by 5.88%
$39 Notification of cessation of securities - EMD 30 Jan 2024 11:11AM $0.050 $0.048 fallen by 4%
$39 Emyria Receives $2.5M R&D Tax Incentive Refund 15 Jan 2024 9:29AM $0.067 $0.048 fallen by 28.36%
$39 Company Overview and Strategic Update 10 Jan 2024 9:31AM $0.059 $0.048 fallen by 18.64%
$39 Emyria Specialist Granted Authorised Prescriber Status 10 Jan 2024 9:28AM $0.059 $0.048 fallen by 18.64%
$39 Change of Director's Interest Notice - M. Winlo 2 Jan 2024 7:43PM $0.055 $0.048 fallen by 12.73%
$39 Change in Substantial Holding 27 Nov 2023 8:21AM $0.074 $0.048 fallen by 35.14%
$39 Notification of cessation of securities - EMD 27 Nov 2023 8:19AM $0.074 $0.048 fallen by 35.14%
$39 Initial Director's Interest Notice - G. Hutchinson 22 Nov 2023 8:59AM $0.074 $0.048 fallen by 35.14%
$39 Final Director's Interest Notice - S. Washer 22 Nov 2023 8:58AM $0.074 $0.048 fallen by 35.14%
$39 Eminent Healthcare Leader New Independent Non-Exec Chair 21 Nov 2023 9:45AM $0.072 $0.048 fallen by 33.33%
$39 Application for quotation of securities - EMD 21 Nov 2023 9:42AM $0.072 $0.048 fallen by 33.33%

176 - 200 of 555 results

Page 8 of 23

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.